# Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy

> **NCT01207908** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 44 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** IGF-1

## Key facts

- **NCT ID:** NCT01207908
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-10
- **Final completion:** 2013-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-01-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207908, "Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01207908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*